Compare Enveric Biosciences Inc (ENVB) vs KeyCorp (KEY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs KeyCorp — how do they compare? Enveric Biosciences Inc trades at $1.32 (market cap $5.32M), while KeyCorp trades at $23.83 (market cap $25.40B). The key difference: KeyCorp is far larger — about 4774.4× Enveric Biosciences Inc's market cap, and KeyCorp pays a 3.48% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | KEY | |
|---|---|---|
Market Cap | $5.32M | $25.40B |
Sector | Health | Financials |
52-Week High | $17.40 | $23.53 |
52-Week Low | $1.28 | $16.78 |
Enterprise Value | $408.82K | — |
Dividend Yield | — | 3.48% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
KeyCorp (KEY) trades at $23.30, up 0.34% with a bullish technical outlook supported by moving averages. The stock shows strong fundamental recovery with Q1 2026 EPS beating expectations at $0.44 and net income margin improving to 26.05%. Recent corporate developments include a $0.21 dividend declaration and a new $3 billion buyback program representing 12% of market cap, signaling management confidence in capital returns.
With 61% analyst buy ratings and a $29.32 consensus price target suggesting 26% upside, KEY presents a compelling value opportunity. However, investors should monitor the bank's ability to sustain revenue growth above $7 billion and navigate potential interest rate volatility that could impact net interest income margins.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About KeyCorp
With assets of over $170 billion, Ohio-based KeyCorp's bank footprint spans 16 states, but it is predominantly concentrated in its two largest markets: Ohio and New York. KeyCorp is primarily focused on serving middle-market commercial clients through a hybrid community/corporate bank model.
Read more on KEY →
